Skip to main navigation Skip to search Skip to main content

Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: A multicentre, phase 1/2, open-label, dose-escalation study

  • Irene M. Ghobrial
  • , Edie Weller
  • , Ravi Vij
  • , Nikhil C. Munshi
  • , Ranjit Banwait
  • , Meghan Bagshaw
  • , Robert Schlossman
  • , Renee Leduc
  • , Stacey Chuma
  • , Janet Kunsman
  • , Jacob Laubach
  • , Andrzej J. Jakubowiak
  • , Patricia Maiso
  • , Aldo Roccaro
  • , Philippe Armand
  • , Akari Dollard
  • , Diane Warren
  • , Brianna Harris
  • , Tiffany Poon
  • , Amy Sam
    • Scott Rodig, Kenneth C. Anderson, Paul G. Richardson

Research output: Contribution to journal › Article › peer-review

83   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: A multicentre, phase 1/2, open-label, dose-escalation study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology